Modex Therapeutics, An Opko Health Company

This study tests a new drug, MDX2004, in 235 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must be 18 or older and have at least one measurable t…

This early-phase trial tests a new drug called MDX2001 in people with advanced solid tumors that have spread. The main goals are to check the drug's safety and see if it can shrink tumors. About 285 adults with various cancers like lung, breast, or colon cancer will take part.

This study tests an experimental drug called MDX2003 in about 180 adults with B-cell lymphomas (like diffuse large B-cell lymphoma or follicular lymphoma) that have returned or not improved after at least two prior treatments. The main goals are to find the safest dose and to see…

This study tests a new drug called MDX2301 to see if it can prevent COVID-19 in healthy adults and those at higher risk for severe illness. About 80 participants will receive either the drug or a placebo by injection or IV. The main goal is to check safety and how the body respon…